These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8357866)
1. Characterization of polymorphs of a new anti-inflammatory drug. Roston DA; Walters MC; Rhinebarger RR; Ferro LJ J Pharm Biomed Anal; 1993; 11(4-5):293-300. PubMed ID: 8357866 [TBL] [Abstract][Full Text] [Related]
2. Characterization of two polymorphs of lornoxicam. Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687 [TBL] [Abstract][Full Text] [Related]
3. Assessment of mefenamic acid polymorphs in commercial tablets using chemometric coupled to MIR and NIR spectroscopies. Prediction of dissolution performance. Antonio M; Maggio RM J Pharm Biomed Anal; 2018 Feb; 149():603-611. PubMed ID: 29202439 [TBL] [Abstract][Full Text] [Related]
4. Thermal, spectroscopic, and ab initio structural characterization of carprofen polymorphs. Bruni G; Gozzo F; Capsoni D; Bini M; Macchi P; Simoncic P; Berbenni V; Milanese C; Girella A; Ferrari S; Marini A J Pharm Sci; 2011 Jun; 100(6):2321-32. PubMed ID: 21246561 [TBL] [Abstract][Full Text] [Related]
5. Far-Infrared Spectroscopy as a Probe for Polymorph Discrimination. Suresh K; Ashe JS; Matzger AJ J Pharm Sci; 2019 May; 108(5):1915-1920. PubMed ID: 30599167 [TBL] [Abstract][Full Text] [Related]
6. Polymorphism of phenylbutazone: properties and compressional behavior of crystals. Ibrahim HG; Pisano F; Bruno A J Pharm Sci; 1977 May; 66(5):669-73. PubMed ID: 874748 [TBL] [Abstract][Full Text] [Related]
8. Characterization of polymorphic ampicillin forms. Baraldi C; Tinti A; Ottani S; Gamberini MC J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347 [TBL] [Abstract][Full Text] [Related]
9. The use of high-speed differential scanning calorimetry (Hyper-DSC) in the study of pharmaceutical polymorphs. McGregor C; Bines E Int J Pharm; 2008 Feb; 350(1-2):48-52. PubMed ID: 17890030 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations. Pallipurath AR; Civati F; Sibik J; Crowley C; Zeitler JA; McArdle P; Erxleben A Int J Pharm; 2017 Aug; 528(1-2):312-321. PubMed ID: 28603011 [TBL] [Abstract][Full Text] [Related]
11. The qualitative and quantitative analysis of chlorpropamide polymorphic mixtures by near-infrared Fourier transform Raman spectroscopy. Tudor AM; Church SJ; Hendra PJ; Davies MC; Melia CD Pharm Res; 1993 Dec; 10(12):1772-6. PubMed ID: 8302765 [TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy. Bellur Atici E; Karlığa B J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262 [TBL] [Abstract][Full Text] [Related]
13. Interrelation between thermochemical and structural data of polymorphs exemplified by diflunisal. Perlovich GL; Hansen LK; Bauer-Brandl A J Pharm Sci; 2002 Apr; 91(4):1036-45. PubMed ID: 11948542 [TBL] [Abstract][Full Text] [Related]
14. Solid state characterization of dehydroepiandrosterone. Chang LC; Caira MR; Guillory JK J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330 [TBL] [Abstract][Full Text] [Related]
15. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. Behme RJ; Brooke D J Pharm Sci; 1991 Oct; 80(10):986-90. PubMed ID: 1784009 [TBL] [Abstract][Full Text] [Related]